ÂÜÀòÂÒÂ×

Sebastien Michel has worked in a variety of roles since 2009. Sebastien began their career as a Research Scientist for the Belgium telethon project at UNamur, followed by an Internship during the master degree at King's College London. In 2015, they took on a Postdoctoral Researcher role at UNIL - Universit\u00e9 de Lausanne. From 2017 to 2021, they worked at Promethera Biosciences as a Discovery and R&D Director, R&D manager, and Senior R&D Scientist. Most recently, they were appointed as Cell Therapy Director at BONE THERAPEUTICS S.A. in 2021 and will start their role as Senior R&D manager at PDC*line Pharma in 2022.

Sebastien Michel attended the University of Namur from 2004 to 2014, during which they obtained a Bachelor's Degree in Biology, General in 2007, a Master's Degree in Cell/Cellular and Molecular Biology in 2009, and a Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology in 2014.